AndrewRobertStiffMD

Internal Medicine • Columbus, OH

Physician

Join to view full profile

Dr. Stiff is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Stiff's full profile

Already have an account?

Office
395 W 12th Ave
Fl 3
Columbus, OH 43210
Phone+1 614-293-3989

Fax+1 614-293-9789

Education & Training

Ohio State University College of MedicineClass of 2015

Certifications & Licensure

OH State Medical License 2019 - 2025
American Board of Internal Medicine Internal Medicine

Publications & Presentations

PubMed

An Open-Label Study of Subcutaneous CpG Oligodeoxynucleotide (PF03512676) in Combination with Trastuzumab in Patients with Metastatic HER2+ Breast Cancer.
Dionisia Quiroga, Robert Wesolowski, Sara Zelinskas, Ashley Pinette, Brooke Benner
Cancer Control. 2024-05-27
1 citations
Single-Cell RNA-Seq Analysis of Patient Myeloid-Derived Suppressor Cells and the Response to Inhibition of Bruton's Tyrosine Kinase.
Himanshu Savardekar, Carter Allen, Hyeongseon Jeon, Jianying Li, Dionisia Quiroga
Molecular Cancer Research. 2024-03-01
Correction: HDAC inhibitor AR-42 decreases CD44 expression and sensitizes myeloma cells to lenalidomide.
Alessandro Canella, Hector Cordero Nieves, Douglas W Sborov, Luciano Cascione, Hanna S Radomska
Oncotarget. 2023-09-25

Journal Articles

Modeling Combination Therapy for Breast Cancer with BET and Immune Checkpoint Inhibitors
Robert Wesolowski, Andrew Stiff, Proceedings of the National Academy of Sciences